Tag: AI

Genomic Testing Cooperative Presents at ASCO meeting Studies Demonstrating the Power of its Liquid Biopsy and Tissue-Based Targeted Transcriptomic Approach when Combined with Artificial Intelligence

May 31, 2023

Irvine, California– May 31, 2023 – Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting three studies  illustrating the power of its proprietary RNA next generation sequencing (NGS) approach in advancing liquid biopsy and tissue-based precision testing.  

Read More »

New publication on how cfRNA and AI are advancing LBx

May 23, 2023

GTC has a new publication in Heliyon titled “The Potential of Cell-Free RNA in Liquid Biopsy: Comprehensive Analysis of Mutation Profile, Chromosomal Abnormalities, and Immune Biomarkers”. This study explores the potential of cell-free RNA (cfRNA) and AI as valuable components of liquid biopsy for evaluating the host immune system and

Read More »

Genomic Testing Cooperative to Present at the AACR 2023 Meeting

April 11, 2023

Demonstrating Reliability of Targeted Transcriptomic Profiling in Predicting Levels of HER2, ER, PD-L1 and Other Immunohistochemistry-based Biomarkers when Combined with Artificial Intelligence Irvine, California– April 11, 2023 – Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting data at the 2023 American Association of Cancer Research (AACR) Annual

Read More »

Press Release – Genomic Testing Cooperative

November 1, 2018

Genomic Testing Cooperative, a Limited Cooperative Association, Launches a New Platform for Affordable Genomic Cancer Profiling Irvine, California-November 1, 2018 – Genomic Testing Cooperative (GTC), a Limited Cooperative Association, announced today that it will offer multiple laboratory-developed genomic profiling tests for hematologic and solid tumors using next-generation sequencing (NGS) technology. The

Read More »